Announcements Trials

Browse Landscape

Phase

Status

Completed 167 Unknown 53 Terminated 39 Withdrawn 14 Active not recruiting 8 Recruiting 6 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1 Gastrointestinal 1

Conditions

Liver Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

Gemcitabine 7 Specimen Handling 6 Oxaliplatin 5 Irinotecan 5 S 1 (combination) 4 Magnetic Resonance Spectroscopy 4 Leucovorin 4 Fluorouracil 4 Capecitabine 4 Biopsy 4 Bevacizumab 4 Radiotherapy 3 Nivolumab 3 Immunotherapy 3 Drug Therapy 3 Albumin-Bound Paclitaxel 3 130-nm albumin-bound paclitaxel 3 trifluridine tipiracil drug combination 2 titanium silicide 2 spartalizumab 2 lenvatinib 2 aldesleukin 2 Taxes 2 Surgical Procedures, Operative 2 Radiosurgery 2 Photochemotherapy 2 Interleukin-2 2 Endoscopic Mucosal Resection 2 Cyclophosphamide 2 Cisplatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Sorafenib × Gastrointestinal × Clear all

NCT05033522 2025-10-23

ALIVE

Mirror Biologics, Inc.

Phase 2/3 Suspended

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡